IL1B and myeloid sarcoma: MS patients often complain of a higher fatigue level during relapses, which are characterized by an increased immune activation, representing an up-modulation of pro-inflammatory cytokines such as TNF-α, IL-1, IL-6, and lymphotoxin-α (52, 54–56).